The impact of zoledronic acid therapy in
โ
Kostantinos Zarogoulidis; Eufimia Boutsikou; Pavlos Zarogoulidis; Ellada Elefthe
๐
Article
๐
2009
๐
John Wiley and Sons
๐
French
โ 213 KB
๐ 2 views
## Abstract Bone metastases occur in 20โ40% of patients with lung cancer. Recent studies demonstrate a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors, which may influence the survival. Therefore, we examined the clinical impact of zoledronic acid (ZOL; Zometa